Clopidogrel-associated acute migratory arthritis following kidney-pancreas transplantation
ASR Muthusamy, A Vaidya… - International journal of …, 2006 - journals.sagepub.com
Clopidogrel is a potent inhibitor of platelet aggregation and has been used as an alternative,
or as an adjunct to aspirin in reducing the risk of thrombosis. A 34-year-old uremic type 1 …
or as an adjunct to aspirin in reducing the risk of thrombosis. A 34-year-old uremic type 1 …
Clopidogrel-associated acute migratory arthritis following kidney-pancreas transplantation
ASR Muthusamy, A Vaidya… - International journal of …, 2006 - pubmed.ncbi.nlm.nih.gov
Clopidogrel is a potent inhibitor of platelet aggregation and has been used as an alternative,
or as an adjunct to aspirin in reducing the risk of thrombosis. A 34-year-old uremic type 1 …
or as an adjunct to aspirin in reducing the risk of thrombosis. A 34-year-old uremic type 1 …
Clopidogrel-associated acute migratory arthritis following kidney-pancreas transplantation.
AS Muthusamy, A Vaidya, PJ Friend - International Journal of …, 2006 - europepmc.org
Clopidogrel is a potent inhibitor of platelet aggregation and has been used as an alternative,
or as an adjunct to aspirin in reducing the risk of thrombosis. A 34-year-old uremic type 1 …
or as an adjunct to aspirin in reducing the risk of thrombosis. A 34-year-old uremic type 1 …
Clopidogrel-associated acute migratory arthritis following kidney-pancreas transplantation.
A Muthusamy, A Vaidya, P Friend - International journal of …, 2006 - ora.ox.ac.uk
Clopidogrel is a potent inhibitor of platelet aggregation and has been used as an alternative,
or as an adjunct to aspirin in reducing the risk of thrombosis. A 34-year-old uremic type 1 …
or as an adjunct to aspirin in reducing the risk of thrombosis. A 34-year-old uremic type 1 …